What's the difference between being prescribed a GLP-1 for type 2 diabetes versus for weight management alone?

The medication class is the same, but the specific drug, dose, and approved indication can differ. In Canada, for example, Ozempic is approved specifically for type 2 diabetes while Wegovy (same active ingredient, semaglutide) is approved for chronic weight management at a different dose, similarly, Mounjaro is approved for diabetes while Zepbound (both tirzepatide) is approved for weight loss. The eligibility criteria and what insurance is willing to cover can also differ significantly between the two indications, even when the underlying drug is essentially the same. References: https://obesitycanada.ca/healthcare-professionals/adult-clinical-practice-guideline/ https://guidelines.diabetes.ca/GuideLines/media/Docs/Quick%20Reference%20Guide/2024-CPG-Quick-Reference-Guide.pdf